COPANLISIB AND VOLASERTIB OVERCOME IBRUTINIB‐VENETOCLAX RESISTANCE VIA TARGETING PI3K‐AKT SIGNALING AND G2/M CELL CYCLE TRANSITION IN MANTLE CELL LYMPHOMA. (12th June 2019) - Zhang, R.; Lee, W.; Huang, S.; Liu, Y.; Leeming, A.H.; McIntosh, J.M.; Nomie, K.J.; Jiang, C.V.; Wang, M.